Hans Henrik Parving

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Marc A. Pfeffer, Emmanuel A. Burdmann, Chao Yin Chen et al. · New England Journal of Medicine · 2009 · 2.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

Nish Chaturvedi, Massimo Porta, Ronald Klein et al. · The Lancet · 2008 · 450 citations

Medicine, Ophthalmology, Pharmacotherapy +13

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

Anne Katrin Sjølie, Ronald Klein, Massimo Porta et al. · The Lancet · 2008 · 432 citations

Medicine, Ophthalmology, Pharmacotherapy +11

Is diabetic nephropathy an inherited complication?

Knut Borch‐Johnsen, Kirsten Nørgaard, E. Hommel et al. · Kidney International · 1992 · 304 citations · Full text

Medicine, Endocrinology, Nephrology +12

Comparison of Different Measures of Urinary Protein Excretion for Prediction of Renal Events

Hiddo J.L. Heerspink, Ron T. Gansevoort, Barry M. Brenner et al. · Journal of the American Society of Nephrology · 2010 · 191 citations · Full text

Medicine, Endocrinology, Nephrology +17